Postoperative administration of monophasic combined oral contraceptives after laparoscopic treatment of ovarian endometriomas: A prospective, randomized trial
L. Muzii et al., Postoperative administration of monophasic combined oral contraceptives after laparoscopic treatment of ovarian endometriomas: A prospective, randomized trial, AM J OBST G, 183(3), 2000, pp. 588-592
OBJECTIVE: We sought to evaluate the efficacy of postoperative administrati
on of monophasic, combined, low-dose oral contraceptives on endometrioma re
currence and on persistence-recurrence of associated pain symptoms after la
paroscopic treatment of moderate-to-severe endometriosis.
STUDY DESIGN: In a prospective, randomized trial 70 patients who were not a
ttempting to conceive, aged 20 to 35 years, underwent laparoscopic excision
of ovarian endometriomas, followed by either postoperative administration
of low-dose cyclic oral contraceptives for 6 months or no treatment on the
basis of a computer-generated sequence. At 3 and 6 months after surgery and
then at 6-month intervals, both groups underwent ultrasonographic examinat
ion for possible evidence of endometrioma recurrence and for evaluation of
the absence, persistence, or recurrence of pain symptoms.
RESULTS: Two patients in the oral contraceptive group did not complete the
study. After a mean follow-up of 22 months (range, 12-48 months), there wer
e 2 (6.1%) endometrioma recurrences in the 33 patients who received postope
rative oral contraceptives versus 1 (2.9%) recurrence in the 35 patients in
the control group (not significant). The moderate-to-severe pain recurrenc
e rate was 9.1% in the oral contraceptive group versus 17.1% in the control
group (not significant). The mean time to recurrence of either symptoms or
endometriomas was 18.2 months in the oral contraceptive group versus 12.7
months in the control group. The 12-month cumulative recurrence rate at lif
e-table analysis was significantly lower for patients receiving oral contra
ceptives versus control subjects, whereas no significant difference was evi
dent at 24 and 36 months.
CONCLUSION: Postoperative administration of low-dose cyclic oral contracept
ives does not significantly affect the long-term recurrence rate of endomet
riosis after surgical treatment. A delay in recurrence is evident at life-t
able analysis.